A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region

The World Health Organization’s Western Pacific Region is responsible for one-fourth of the global cervical cancer burden, and nearly 90% of that burden is concentrated in middle-income countries (MICs). Applying a conceptual model of implementation of population-based interventions, we synthesized...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rei Haruyama, Sumiyo Okawa, Hiroki Akaba, Hiromi Obara, Noriko Fujita
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/3241ac8944d24e0abf23145f669d4e84
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3241ac8944d24e0abf23145f669d4e84
record_format dspace
spelling oai:doaj.org-article:3241ac8944d24e0abf23145f669d4e842021-11-25T19:11:35ZA Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region10.3390/vaccines91113552076-393Xhttps://doaj.org/article/3241ac8944d24e0abf23145f669d4e842021-11-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1355https://doaj.org/toc/2076-393XThe World Health Organization’s Western Pacific Region is responsible for one-fourth of the global cervical cancer burden, and nearly 90% of that burden is concentrated in middle-income countries (MICs). Applying a conceptual model of implementation of population-based interventions, we synthesized the current implementation status of human papillomavirus (HPV) vaccination and national plans that form the basis of its implementation in 17 MICs. We gathered information from a range of governmental documents, published studies, and global databases. For all available national cancer-related plans and immunization plans, we examined the description of HPV vaccination. We found that, as of July 2021, only four countries (24%) had a mature HPV vaccination program with a high first-dose coverage; three (18%) had introduced HPV vaccination, but needed further efforts to scale it up, seven (41%) had not been able to introduce it after conducting demonstration projects, and three (18%) did not have any experience in HPV vaccination. In the national plans, most of the countries recognized the importance of HPV vaccination, but only 10 (59%) provided an implementation strategy on how it would be introduced or scaled up. Countries with a mature program were more likely to have their implementation strategy detailed in their national cancer control plan. Successful implementation of HPV vaccination requires overcoming known challenges and having a clear national plan. Positioning HPV vaccination clearly in the overall national cancer control plan may be key to accelerating its nationwide implementation.Rei HaruyamaSumiyo OkawaHiroki AkabaHiromi ObaraNoriko FujitaMDPI AGarticlecervical cancerHPV vaccinationWestern Pacific RegionMedicineRENVaccines, Vol 9, Iss 1355, p 1355 (2021)
institution DOAJ
collection DOAJ
language EN
topic cervical cancer
HPV vaccination
Western Pacific Region
Medicine
R
spellingShingle cervical cancer
HPV vaccination
Western Pacific Region
Medicine
R
Rei Haruyama
Sumiyo Okawa
Hiroki Akaba
Hiromi Obara
Noriko Fujita
A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region
description The World Health Organization’s Western Pacific Region is responsible for one-fourth of the global cervical cancer burden, and nearly 90% of that burden is concentrated in middle-income countries (MICs). Applying a conceptual model of implementation of population-based interventions, we synthesized the current implementation status of human papillomavirus (HPV) vaccination and national plans that form the basis of its implementation in 17 MICs. We gathered information from a range of governmental documents, published studies, and global databases. For all available national cancer-related plans and immunization plans, we examined the description of HPV vaccination. We found that, as of July 2021, only four countries (24%) had a mature HPV vaccination program with a high first-dose coverage; three (18%) had introduced HPV vaccination, but needed further efforts to scale it up, seven (41%) had not been able to introduce it after conducting demonstration projects, and three (18%) did not have any experience in HPV vaccination. In the national plans, most of the countries recognized the importance of HPV vaccination, but only 10 (59%) provided an implementation strategy on how it would be introduced or scaled up. Countries with a mature program were more likely to have their implementation strategy detailed in their national cancer control plan. Successful implementation of HPV vaccination requires overcoming known challenges and having a clear national plan. Positioning HPV vaccination clearly in the overall national cancer control plan may be key to accelerating its nationwide implementation.
format article
author Rei Haruyama
Sumiyo Okawa
Hiroki Akaba
Hiromi Obara
Noriko Fujita
author_facet Rei Haruyama
Sumiyo Okawa
Hiroki Akaba
Hiromi Obara
Noriko Fujita
author_sort Rei Haruyama
title A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region
title_short A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region
title_full A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region
title_fullStr A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region
title_full_unstemmed A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region
title_sort review of the implementation status of and national plans on hpv vaccination in 17 middle-income countries of the who western pacific region
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/3241ac8944d24e0abf23145f669d4e84
work_keys_str_mv AT reiharuyama areviewoftheimplementationstatusofandnationalplansonhpvvaccinationin17middleincomecountriesofthewhowesternpacificregion
AT sumiyookawa areviewoftheimplementationstatusofandnationalplansonhpvvaccinationin17middleincomecountriesofthewhowesternpacificregion
AT hirokiakaba areviewoftheimplementationstatusofandnationalplansonhpvvaccinationin17middleincomecountriesofthewhowesternpacificregion
AT hiromiobara areviewoftheimplementationstatusofandnationalplansonhpvvaccinationin17middleincomecountriesofthewhowesternpacificregion
AT norikofujita areviewoftheimplementationstatusofandnationalplansonhpvvaccinationin17middleincomecountriesofthewhowesternpacificregion
AT reiharuyama reviewoftheimplementationstatusofandnationalplansonhpvvaccinationin17middleincomecountriesofthewhowesternpacificregion
AT sumiyookawa reviewoftheimplementationstatusofandnationalplansonhpvvaccinationin17middleincomecountriesofthewhowesternpacificregion
AT hirokiakaba reviewoftheimplementationstatusofandnationalplansonhpvvaccinationin17middleincomecountriesofthewhowesternpacificregion
AT hiromiobara reviewoftheimplementationstatusofandnationalplansonhpvvaccinationin17middleincomecountriesofthewhowesternpacificregion
AT norikofujita reviewoftheimplementationstatusofandnationalplansonhpvvaccinationin17middleincomecountriesofthewhowesternpacificregion
_version_ 1718410146080620544